Literature DB >> 16021139

Response of deep cutaneous vasculitis to infliximab.

Imad W Uthman, Zahi Touma, Jinan Sayyad, Salah Salman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16021139     DOI： 10.1016/j.jaad.2005.02.009

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors:  Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

2.  Infliximab for idiopathic deep cutaneous vasculitis refractory to cyclophosphamide.

Authors:  Marcelo Derbli Schafranski; Giuliano Doretto Campanari
Journal:  Int J Vasc Med       Date:  2010-06-27

Review 3.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.